Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.02 USD | -0.99% | +0.95% | -4.70% |
May. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 30 | Catalyst Pharmaceuticals Gets FDA Approval for Dose Increase in LEMS Drug | MT |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 543M | Capitalization | 1.89B |
---|---|---|---|---|---|
Net income 2024 * | 117M | Net income 2025 * | 161M | EV / Sales 2024 * | 3.09 x |
Net cash position 2024 * | 469M | Net cash position 2025 * | 700M | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
12.5
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on Catalyst Pharmaceuticals, Inc.
1 day | -0.99% | ||
1 week | +0.95% | ||
Current month | -0.93% | ||
1 month | +8.83% | ||
3 months | -5.82% | ||
6 months | +8.10% | ||
Current year | -4.70% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Richard Daly
CEO | Chief Executive Officer | 62 | 15-02-18 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | Dec. 31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 15-02-18 |
David Tierney
BRD | Director/Board Member | 60 | 02-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.05% | 28 M€ | -2.99% | ||
0.32% | 25 M€ | -4.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 16.04 | -0.87% | 690,494 |
24-06-03 | 16.18 | +0.06% | 978,672 |
24-05-31 | 16.17 | +0.37% | 666,538 |
24-05-30 | 16.11 | +1.45% | 1,096,467 |
24-05-29 | 15.88 | -4.16% | 839,984 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.70% | 1.91B | |
-1.62% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- CPRX Stock